Raleigh, NC, United States of America

Kristine Mondorf

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristine Mondorf. Retrieved from https://idiyas.com/inventor/kristine-mondorf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kristine Mondorf: Innovator in Affinity Purification

Introduction

Kristine Mondorf is a notable inventor based in Raleigh, NC (US). She has made significant contributions to the field of biochemistry, particularly in the area of affinity purification. Her work has implications for various applications in medical and research settings.

Latest Patents

Kristine Mondorf holds a patent for "Peptide ligands for affinity purification of fibrinogen." This invention discloses peptides that bind to fibrinogen, featuring specific sequences such as Trp-Gln-Glu-His-Tyr-Asn, Trp-Gln-Glu-Thr-Tyr-Gln, and Tyr-Glu-Asn-Tyr-Gly-Tyr. These peptides can be immobilized on a chromatographic substrate, making them useful in an affinity chromatography process to purify fibrinogen. She has 1 patent to her name.

Career Highlights

Kristine is currently employed at Bayer Corporation, where she continues to advance her research and development efforts. Her work at Bayer has allowed her to explore innovative solutions in the field of biochemistry.

Collaborations

Some of her notable coworkers include Ruben C Carbonell and Joseph A Buettner. Their collaboration has contributed to the advancement of research in their respective fields.

Conclusion

Kristine Mondorf is a pioneering inventor whose work in peptide ligands has the potential to enhance affinity purification processes. Her contributions to the field are invaluable and continue to influence biochemistry research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…